Le Lézard
Classified in: Science and technology
Subjects: PDT, VET

Coding For Veterans Opens the Market


TORONTO, Nov. 10, 2023 /PRNewswire/ - Minister of Labour, Immigration, Training and Skills Development David Piccini joined Jeff Musson, Executive Director of Coding for Veterans, and Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to open the market and honour military veterans and members of the Canadian Armed Forces, as well as to commemorate Remembrance Day.

Coding for Veterans retrains military veterans across North America in software development and cyber security. The program is delivered 100% online through the University of Southern California and, in Canada, through the University of Ottawa. From deployment to employment, Coding for Veterans has helped arm more than 500 servicemen and women with new skills to protect our digital borders in cyber security since 2019. To learn more, please visit https://www.codingforveterans.com/

CNW sponsored announcement. To learn more visit www.newswire.ca

SOURCE Toronto Stock Exchange


These press releases may also interest you

at 07:00
In Phase Ia clinical study, GZR4 demonstrated favorable safety and tolerability profiles in healthy subjects, maintaining a stable glucose-lowering effect for up to one week with a single administration.In Phase Ib clinical study, patients with Type...

at 06:52
With cross-border trade representing a new direction for e-commerce in recent years, cross-border e-commerce in Chengdu has experienced explosive growth. Its public service platforms completed more than 61 million import and export declarations in...

at 06:26
At RE+ 2024, Sunwoda made a significant impact under the theme "Sunwoda Inside," underscoring its leadership in providing end-to-end energy storage solutions. With 27 years of experience in battery technology, Sunwoda has developed a comprehensive...

at 06:00
BioInvent International (STO:BINV)Preliminary data presented at ESMO 2024 demonstrate BT-001 induces tumor regression in patients who failed previous anti-PD(L)-1 treatmentIn a patient with a heavily pretreated leiomyosarcoma, BT-001 was able to...

at 05:18
Mox Capital, a trailblazer in alternative investments with AUM of US$1.4 billion, is announcing its strategic support for a vast array and variety of regional high-potential startups. According to COO Nguyen Dinh Giang, Mox Capital seeks to reinforce...

at 05:00
Updated Phase 1 dose-escalation data from ARROS-1 and ALKOVE-1 clinical trials continue to support potential best-in-class profiles for zidesamtinib and NVL-655 Rapid enrollment in Phase 2 portions of the ARROS-1 and ALKOVE-1 clinical trials;...



News published on and distributed by: